Cargando…

Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas

ERα, ERβ, PR, ERα36, EGFR and HER2 mRNA and protein expression in papillary thyroid carcinoma (PTC) were examined by real time RT-PCR and immunohistochemical staining. The mRNA and protein expression of ERα and PR were gradually increased and those of ERβ were gradually decreased from normal thyroid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Yu-Jie, Qiu, Yi-Bo, Jiang, Rong, Xu, Man, Zhao, Le, Chen, George G., Liu, Zhi-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612999/ https://www.ncbi.nlm.nih.gov/pubmed/28947799 http://dx.doi.org/10.1038/s41598-017-12478-1

Ejemplares similares

PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio
por: Qiu, Yi-Bo, et al.
Publicado: (2019)

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway
por: Zhu, Linlin, et al.
Publicado: (2018)

Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma
por: Eldien, Marwa Mohammed Serag, et al.
Publicado: (2017)

Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
por: Yin, Li, et al.
Publicado: (2014)

A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells
por: Zhang, XianTian, et al.
Publicado: (2010)

HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma
por: Zhang, Lili, et al.
Publicado: (2022)

The Role of ERα36 in Development and Tumor Malignancy
por: Thiebaut, Charlène, et al.
Publicado: (2020)

Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer
por: Podetta, Michele, et al.
Publicado: (2018)

EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma
por: Xue, Liqiong, et al.
Publicado: (2019)

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
por: Acramel, Alexandre, et al.
Publicado: (2022)

Concomitant medullary thyroid carcinoma with paraganglioma-like pattern and papillary thyroid carcinoma
por: Greco, C, et al.
Publicado: (2019)

Multimodality MRI-based radiomics for aggressiveness prediction in papillary thyroid cancer
por: Dai, Zedong, et al.
Publicado: (2022)

The indices of body size and aggressiveness of papillary thyroid carcinoma
por: Kim, Ju-Yeon, et al.
Publicado: (2011)

Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
por: Benvenga, Salvatore, et al.
Publicado: (2014)

Management of the Patient with Aggressive and Resistant Papillary Thyroid Carcinoma
por: Miftari, Rame, et al.
Publicado: (2016)

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas
por: Jin, Meihua, et al.
Publicado: (2021)

Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas
por: Warda, Firas, et al.
Publicado: (2022)

ERα-36 regulates progesterone receptor activity in breast cancer
por: Konan, Henri-Philippe, et al.
Publicado: (2020)

Carvacrol: An In Silico Approach of a Candidate Drug on HER2, PI3Kα, mTOR, hER-α, PR, and EGFR Receptors in the Breast Cancer
por: Herrera-Calderon, Oscar, et al.
Publicado: (2020)

Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer
por: Wang, Li, et al.
Publicado: (2016)

Magnetic resonance imaging in the prediction of aggressive histological features in papillary thyroid carcinoma
por: Song, Bin, et al.
Publicado: (2018)

Concomitant uveal melanoma and papillary thyroid carcinoma: a case report
por: Kolaii, Seiiedeh Samaneh Taghian Jamaleddin, et al.
Publicado: (2022)

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)

LGR5 is associated with tumor aggressiveness in papillary thyroid cancer
por: Michelotti, Gregory, et al.
Publicado: (2015)

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma
por: Teng, Huajing, et al.
Publicado: (2018)

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer
por: Omarjee, S, et al.
Publicado: (2017)

ODP471 Concomitant Metastatic Papillary Thyroid Cancer and Graves’ Disease Presenting as Thyroid Storm
por: Parihar, Aisha, et al.
Publicado: (2022)

Histogram-based analysis of diffusion-weighted imaging for predicting aggressiveness in papillary thyroid carcinoma
por: Wei, Ran, et al.
Publicado: (2022)

ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity
por: Oueslati, Mohamed, et al.
Publicado: (2017)

Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
por: Lee, Cho Rok, et al.
Publicado: (2017)

Recurrent Aggressive Fibromatosis Coexisting With Papillary Carcinoma Thyroid – Case Report
por: BG, Bharath, et al.
Publicado: (2023)

Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm
por: Lee, Jin Seok, et al.
Publicado: (2022)

The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
por: Sheikh-Ahmad, Mohammad, et al.
Publicado: (2023)

Nomogram incorporating preoperative clinical and ultrasound indicators to predict aggressiveness of solitary papillary thyroid carcinoma
por: Liu, Long, et al.
Publicado: (2023)

ODP493 Malignant Struma Ovarii with Papillary Thyroid Carcinoma and concomitant High Risk Thyroid Nodule
por: Chaidarun, Tanyawan, et al.
Publicado: (2022)

Effects of concomitant obesity and diabetes on the aggressiveness and outcomes of differentiated thyroid cancer patients
por: Elbasan, Onur, et al.
Publicado: (2021)

Is aggressive digital papillary adenocarcinoma really aggressive digital papillary adenocarcinoma?
por: Chen, Sheng, et al.
Publicado: (2014)

ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway
por: Li, Guangliang, et al.
Publicado: (2020)

Anti-N-methyl-D-aspartate Encephalitis Concomitantly with Tall-cell Variant Papillary Thyroid Carcinoma
por: Mahadeen, Ahmad, et al.
Publicado: (2019)

Huaier polysaccharide inhibits the stem-like characteristics of ERα-36(high) triple negative breast cancer cells via inactivation of the ERα-36 signaling pathway
por: Hu, Baoquan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5sbs9bn018k4u9n17ed5mv8tnm